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Objective: This study was conducted to investigate patients with bladder pain syndrome (BPS) and
cystoscopic ﬁndings of Hunner’s lesion. The treatment and pathological ﬁndings related to Hunner’s
ulcers are unclear. The purpose of this study is to clarify the characteristics and to develop a new method
for the diagnosis and treatment of Hunner’s lesions in patient with BPS.
Methods: From 2005 to 2011, 12 women with BPS were found to have bladder ulcers by cystoscopy
without anesthesia. Previous therapy results for these patients had been limited. All patients received a
bladder ulcer biopsy and cystoscopic electrocauterization in our hospital as treatment for the bladder
ulcers. Patient demographics, patient clinical history, the characteristics of the cystoscopic ﬁndings, and
treatment outcomes were recorded.
Results: The cystoscopy characteristics of the bladder ulcers were central hyperemic patches with pe-
ripheral scarring and increased vascularity. Several subtypes of cystoscopic ﬁnding were also identiﬁed.
The pathology ﬁndings of these patients included chronic cystitis with ulceration or eosinophilic cystitis.
Mast cells and macrophages were also found in the bladder mucosa by immunohistochemical staining
for c-kit and CD68. Nine of the 12 patients were immediately pain-free after electrocauterization, and the
other three also showed a marked improvement. The patients’ mean Visual Analogue Score before the
operation was 9.64  0.81, and their mean Visual Analogue Score after electrocauterization showed
signiﬁcant improvement (2.95  1.85, p < 0.001). Bladder pain relapse occurred at 2e4 months after the
procedure in six patients.
Conclusion: Patients with BPS who show a poor response to conventional intravesical treatments should
receive cystoscopy to identify ulcer type BPS. Treatment of patients by transurethral electrocauterization
when they have ulcer type BPS is able to provide pain relief.
Copyright  2013, Taiwan Urological Association. Published by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license.1. Introduction
Patients who suffer from bladder pain without infection, uro-
thelial tumor, urolithiasis, or other organic diseases affecting the
genitourinary tract are often diagnosed as suffering from interstitial
cystitis (IC). Current consensus suggests that the term IC is
misleading and should be replaced by “bladder pain syndrome”
(BPS).1 IC/BPS can be subdivided into two types, ulcerative and
nonulcerative, as determined by cystoscopic ﬁndings indicating
either bladder ulcers or glomerulations on the bladder wall without
ulceration. Bladder ulcerations was used to be known as Hunner’sddhist Tzu Chi General Hos-
aiwan.
ciation. Published by Elsevier Taiwulcer in the past decades, and in recent years, the European Urology
Association guideline opted to use the term Hunner’s lesion instead
of Hunner’s ulcer, and this is gradually being adopted worldwide.
Hunner’s lesions are found in about 10% to 20% of patients with
IC/BPS.2 Some studies have asserted that patients with Hunner’s
lesions tend to be older, to have a smaller bladder capacity, and to
have a higher urinary frequency than patients without Hunner’s
lesions.3,4 However, another study did not agree with this conclu-
sion.5 In our experience, patients with IC/BPS and bladder ulcera-
tion often suffer from intractable lower abdominal pain, and this
pain usually does not respond to medical treatment.
Although numerous studies have focused on the pathophysi-
ology of IC/BPS, the actual etiology, pathogenesis, and diagnostic
criteria of bladder ulcers remain unclear, and there is also no def-
inite treatment method. In clinical practice, we observed 12an LLC. Open access under CC BY-NC-ND license.
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treatment. In this study, we try to characterize the cystoscopic
ﬁndings related to Hunner’s lesions and propose a new method
for the diagnosis and treatment of Hunner’s lesions in patients with
IC/BPS.
2. Materials and methods
This is a retrospective longitudinal study. From 2005 to 2011,
among 95 patients diagnosed to have IC/BPS, 12 women (12.6%)
were found to have Hunner’s lesions. The lesions were deﬁned as a
circumscript, reddened mucosal area with small vessels radiating
toward a central scar, or a discontinuity or break lesion or patch of
bladder mucosa.1 These patients had suffered from severe bladder
pain and urinary frequency for several years, and all of these pa-
tients were found to have bladder ulcers by cystoscopy without
anesthesia. The patient demographics, clinical history, treatment,
and cystoscopic ﬁndings are reported. The Visual Analogue Score
(VAS) of painwas also recorded before and after the operation. This
study was approved by Buddhist Tzu Chi General Hospital Research
Ethics Committee, and written informed consent was obtained
from each patient.
3. Results
Since August 2011, we have attempted to discover possible
bladder lesions in the patients who have failed to respond suc-
cessfully to intravesical treatment. Cystoscopy without anesthesia
was performed on patients who had intractable bladder pain when
the bladder was nondistended, and those who had frequency, ur-
gency, and had shown abnormally increased vascularity and hy-
peremic patches during previous cystoscopic hydrodistention
investigations. Among patients receiving cystoscopic examination,
12 were found to have deﬁnite bladder lesions. The demographics
of these patients are listed in Table 1. Their ages ranged from 45 to
73 years, and the duration of treatment for IC/BPS ranged from 1 to
13 years. All patients had been previously diagnosed to have IC/BPS
by cystoscopic hydrodistention under general anesthesia.
These patients had previously received various types of medi-
cation such as anticholinergic drugs, nonsteroid anti-inﬂammatory
drugs (NSAIDs), analgesics, and oral pentosanpolysulfate (Elmiron),
but the therapeutic effect of these treatments had usually been
disappointing. The patients had also undergone multiple intra-
vesical procedures including cystoscopic hydrodistention, intra-
vesical hyaluronic acid installation, and intravesical botulinum
toxin-A injections. The effects of these intravesical treatmentsTable 1
Demographics of the IC/BPS patients with Hunner’s lesion.
No. Age (y) Disease
history (y)
Location of ulcer Maximum bladde
capacity (mL)
1 64 1 Left posterior wall 300
2 61 5 Right and left posterior wall 450
3 66 9 Posterior wall 550
4 70 4 Left posterior wall 200
5 56 10 Small ulcer over right and
left posterior wall
350
6 45 13 Right posterior wall 400
7 55 6 Right posterior wall 450
8 54 10 Right posterior wall 350
9 73 5 Right posterior wall 300
10 65 2 Left lateral wall 300
11 55 3 Right and left posterior wall 500
12 63 2 Multiple ulcers in posterior wall 550
IC/PBS ¼ interstitial cystitis/bladder pain syndrome.had also been limited or dissatisfactory. Intractable bladder pain
and frequent urination continued to afﬂict these patients. All 12
patients had severely reduced quality of life. They could hardly
leave their home for a trip or for leisure. Four patients had been
treated with long-term antibiotics for pyuria with a negative urine
culture result, but bladder pain and frequent urination remained.
Urodynamic studies universally revealed a small cystometric
bladder capacity and a strongly positive potassium chloride test.
During the cystoscopic procedure, the bladder was not dis-
tended to more than 100 mL, and it was then that the ulcers were
seen. The ulcers were either single or multiple and were mainly
located on the posterior or lateral wall. No ulcer was found in the
trigone. The characteristics of the bladder ulcers were as follows:
(1) hemorrhagic patches without deﬁnite scarring or urothelial
erosion, (2) central hyperemic patches with peripheral scarring, (3)
increased vascularity with a centralized distribution of vessels, (4)
severe scarring with a central scar and hyperemic patch, (5) local-
ized erythema as well as edematous and erosive mucosa, (6) easy
bleeding from the bladder ulcer and a mucosal ﬁssure that
appeared during bladder ﬁlling (Fig. 1AeF). The ulcers were
different from classic ulcers, which have an oval defect or volcano
appearance. Glomerulations of the bladder mucosa at the other
sites may or may not be present when the bladder was further
distended with anesthesia.
Cystoscopic electrocauterization to treat the bladder ulcers was
performed on all patients before bladder hydrodistention. We used
a roller electrode to cauterize the ulcer base and the margin of the
surroundingmucosa as shown in Fig. 2. Bladder biopsy of the ulcers
was performed before electrocauterization. After electro-
cauterization, no bleeding was seen to occur from the ulcer. A
three-way Foley catheter was inserted to allow normal saline
continuous irrigation for 2 days. Prophylactic antibiotics and oral
NSAIDs were also used to provide symptomatic treatment for these
patients. Follow-up cystoscopy was performed at 3 months after
the procedure if patients still had bladder pain symptoms.
A minor bladder perforation during the procedure was noted in
one patient who received extensive cauterization for multiple
bladder ulcers, and with this patient we retained the urethral
catheterization for 1 week (grade I complication of Clavien Classi-
ﬁcation). All patients became pain-free or had reduced pain
immediately after electrocauterization, and the symptoms
remained improved after removal of the catheter. The patients’
mean VAS before the operation was 9.64  0.81, and their mean
VAS after electrocauterization showed signiﬁcant improvement
(2.95  1.85, p < 0.001). The patients with hemorrhagic patches,
increased vascularity, and centralized distribution of vessels in ther Therapeutic duration
of electrocauterization
Biopsy results
2 and 9 mo not recurred yet Chronic cystitis with edema
2, 3, 7 mo not recurred yet Chronic ulcer with granulation tissue
3 and 5 mo not recurred yet Eosinophilic cystitis with granulation tissue
2 and 6 mo not recurred yet Chronic ulcer with granulation tissue.
3 and 4 mo not recurred yet Mixed acute and chronic inﬂammatory
cells inﬁltration
>3 mo Eosinophilic cystitis
>12 mo Chronic cystitis
2 and 4 mo not recurred yet Chronic inﬂammatory with foreign
body giant cells
>4 mo Chronic cystitis
>6 mo Chronic cystitis
>4 mo Chronic cystitis.
>3 mo Eosinophilic cystitis
Fig. 1. Characteristics of the Hunner’s lesion: (A) hemorrhagic patches without deﬁnite scarring or urothelial erosion, (B) central hyperemic patches with peripheral scarring,
(C) increased vascularity with centralized distribution of vessels, (D) severe scarring with a central scar and hyperemic patch, (E) localized erythema and edematous and erosive
mucosa, and (F) the bladder ulcer easily bled and a mucosal ﬁssure appeared during bladder ﬁlling.
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The improvement in patients with only hyperemic patches was not
as good as that of the other patients. Among the 12 patients, six had
recurrent bladder pain 2 to 3 months after the ﬁrst procedure; the
therapeutic duration of electrocauterization is listed in Table 1.
Cystoscopy revealed that new bladder ulcers had formed near the
scars of the previous ulcers, and a second electrocauterization was
performed that gave a similar improvement after the procedure.
The therapeutic duration of electrocauterization has a tendency to
last longer after repeat procedure.
The pathology reports on the bladder biopsies of these patients
revealed lymphocyte inﬁltration with chronic ulceration and the
presence of granulation tissue (Fig. 3A), whereas three of the biopsy
reports showed eosinophilic cystitis (Fig. 3B). Mast cells andFig. 2. Using transurethral roller electrode to cauterize themacrophages were identiﬁed in the bladder mucosa by immno-
histochemical staining for c-kit and CD 68, respectively (Fig. 3C
and D).
4. Discussion
Fenwick6 ﬁrst described nonmalignant bladder ulcers in 1896. In
his case series, many patients had multiple bladder ulcerations that
involved the trigone. Hunner7 presented the ﬁrst report of eight
cases of bladder ulcers in women. Peterson and Hager8 reported a
case series including patients with urinary frequency, suprapubic
pain, and cystoscopic bladder Hunner’s lesions; they chose to call
the disease “interstitial cystitis,” as Skene ﬁrst used this term in his
textbook in 1887. Currently, IC/BPS can be subdivided intoulcer base and the margin of the surrounding mucosa.
Fig. 3. Pathological ﬁndings associated with the Hunner’s lesion: (A) chronic ulceration and the presence of granulation tissue, (B) eosinophilic cystitis, (C) CD68 staining of
macrophages, and (D) c-kit staining of mast cells.
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The study of Peters et al9 found that ulcerative type IC was asso-
ciated with more severe lower urinary tract symptoms and less
coexisting illnesses. He proposed that ulcerative and nonulcerative
IC are two distinct diseases.
In this study, we found that the appearance of bladder ulcers in
IC/BPS patients was not uniform. There was no typical ulcer base or
crater margin; rather, the typical ulcer was formed as a dense
central scarring with eroded mucosa and increased vascularity
radiating from the center to the periphery. The characteristic
cystoscopic ﬁndings related to bladder ulcers indicate the presence
of localized bladder inﬂammation with an unhealthy mucosa. Un-
less the chronic inﬂammatory lesions are ablated, it seems likely
that it will be almost impossible to eradicate bladder pain.
Johansson and Fall10 collected specimens by transurethral
resection of the bladder wall from patients with ulcerative and
nonulcerative IC. Patients with ulcerative IC showed mucosal ul-
ceration and hemorrhage, tissue granulation, intense inﬂammatory
inﬁltration, elevated mast cell counts, and perineural inﬁltrates.
Patients with nonulcer IC, despite displaying the same severe
symptoms, had relatively unaltered mucosa with a sparse inﬂam-
matory response. In the present study, bladder biopsy frompatients
with Hunner’s lesion showed bladder mucosa ulceration,
lymphocyte inﬁltration, and tissue granulation. Eosinophilic cystitis
was also detected in three of the 12 patients. The patients witheosinophilic cystitis might be treated with steroid or montelukast
sodium if bladder pain persisted after current therapy.11,12 Further
immunochemical stain revealed mast cell and macrophage accu-
mulation in the bladder submucosa. Because the presence of
macrophage implies chronic inﬂammation and mast cells imply an
allergic reaction, the underlying pathophysiology of Hunner’s
lesion might be attributed to allergic reaction and chronic
inﬂammation.
Zhang et al13 investigated biomarkers such as antiproliferative
factor, heparin-binding epidermal growth factor (EGF), and EGF in
patients with IC/PBS and found that EGF levels were signiﬁcantly
higher in patients with nonulcerative IC than those with ulcerative
IC. The clinical characteristics of patients with ulcer type IC/BPS in
our series are intractable bladder pain that is not related to bladder
distention as well as manifestation of symptoms such as frequency,
urgency, and nocturia. Therefore, for a patient who has been
diagnosed to have IC/BPS but has bladder pain that persists despite
multiple types of medications and/or intravesical treatment,
cystoscopy without anesthesia should be performed to try and
detect the presence of bladder ulcers.
Many different specialized treatments have been used to treat
ulcer type IC/PBS. Since the early 20th century, segmental resection
of the part of the bladder wall with ulcers has been performed on
patients with ulcer type IC. However, this approach has produced
unsatisfactory results and a great tendency for the ulcers to recur
J.-F. Jhang et al. / Urological Science 24 (2013) 51e55 55after the surgery.8 Rössberger et al14 reported the long-term results
of cystectomy or partial cystectomy with reconstructive surgery for
patients with ulcerative IC/PBS; in this series, 28 of the 34 patients
had complete symptom resolution after this surgical procedure.
Rofeim et al15 used cystoscopic YAG laser to ablate Hunner’s lesion
in 24 patients, and it was found that both pain and lower urinary
tract symptoms were greatly improved after this procedure; how-
ever, some patients needed to undergo a repeat procedure. Soucy
reported his experience using steroids to treat 14 patients with
ulcerative IC/PBS. Nine of these patients showed a response to this
therapy, whereas the others did not.16 Cox et al17 used a submucosal
injection of triamcinolone to treat Hunner’s lesion subtype IC, and
as a result the mean International Prostate Symptom Score
improved after the procedure without any complications. Hyper-
baric oxygen therapy has also been used to treat IC/PBS with
Hunner’s lesion, and after a course involving 20 sessions of hy-
perbaric oxygen therapy, Hunner’s lesion seemed to disappear.18,19
Although many different methods have been used to treat patients
with ulcer type IC/PBS, none seem to be able to deﬁnitely cure this
disease. The American Urological Association guidelines recom-
mended the fulguration (with laser or electrocautery) and/or in-
jection of triamcinolone if Hunner’s lesions are present.20 In this
study, we tried simple electrocauterization using an ordinary
transurethral resectoscope and roller to cauterize the bladder ul-
cers. The results in terms of immediate pain relief were excellent.
Although the IC symptoms did relapse in some patients, a repeat
procedure remained effective.
All 12 patients with ulcer type IC/BPS in this study had failed to
improve when treated previously with oral medication and intra-
vesical treatments including hyaluronic acid instillations and bot-
ulinum toxin A injections. Only electrocauterization was able to
provide relief from their bladder pain symptoms and allow the
patients to attain a better quality of life. We suggest that urologists
use different treatments for patient with ulcerative and non-
ulcerative type IC/BPS. Bladder biopsy of the bladder ulcers should
be performed to identify the underlying pathology, such as eoshi-
nophilic cystitis, and the resulting pathological report may have an
impact on the choice of therapy strategy. The limitations of this
study were the small case number and the retrospective study
design. However, Hunner’s lesions are only found in about 10% of
the patients with IC/BPS.We considered the improvement in VAS as
signiﬁcant, despite the small case number used in this study.
Further prospective study involving a control group should be
considered.
5. Conclusions
Patients with ulcer type IC/BPS should be treated as having a
different disease from patients with nonulcer type IC/BPS. Once a
patient is found to be refractory to conventional intravesical
treatment for IC/BPS and intractable bladder pain persists, cystos-
copy should be performed as early as possible in order to detect
ulcer type IC/BPS. Transurethral electrocauterization of the bladder
ulcers is a simple and effective procedure that brings pain reliefvery quickly. Although symptom relapse may occur, a repeat of the
procedure is usually effective.
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